Tamoxifene (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tamoxifene" in Italian language version.

refsWebsite

Global rank Italian rank

8doi.org

2^nd place

7^th place

5nih.gov

4^th place

9^th place

3oadoi.org

799^th place

22^nd place

2europa.eu

68^th place

57^th place

1worldcat.org

5^th place

26^th place

1news-medical.net

8,069^th place

6,596^th place

1web.archive.org

1^st place

1thebreastonline.com

low place

1embopress.org

low place

1agenziafarmaco.gov.it

low place

1,603^rd place

agenziafarmaco.gov.it

farmaci.agenziafarmaco.gov.it

Riassunto delle caratteristiche del prodotto (Nolvadex), su farmaci.agenziafarmaco.gov.it. URL consultato il 9 dicembre 2018.

doi.org

dx.doi.org

M MOURITS, Tamoxifen treatment and gynecologic side effects: a review, in Obstetrics & Gynecology, vol. 97, n. 5, 2001-05, pp. 855–866, DOI:10.1016/s0029-7844(00)01196-0. URL consultato il 5 dicembre 2018.
subject index, in Toxicology Letters, vol. 122, n. 3, 6 luglio 2001, pp. 271–272, DOI:10.1016/s0378-4274(01)00407-6. URL consultato il 5 dicembre 2018.
Kuhl H., Pharmacology of estrogens and progestogens: influence of different routes of administration, in Climacteric, vol. 8, n. 1, DOI:10.1080/13697130500148875.
Jordan VC (Oct 1993), "Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer"., in British Journal of Pharmacology, vol. 110, n. 2, DOI:10.1111/j.1476-5381.1993.tb13840.x.
Anne Z. Steiner, Mishka Terplan e Richard J. Paulson, Comparison of tamoxifen and clomiphene citrate for ovulation induction: a meta-analysis, in Human Reproduction (Oxford, England), vol. 20, n. 6, 2005-6, pp. 1511–1515, DOI:10.1093/humrep/deh840. URL consultato l'8 gennaio 2019.
Ruth James BA, MEd, FRCS Farid Ahmed MBBS, FRCS Giles Cunnick BSc, MD, FRCS, The Efficacy of Tamoxifen in the Treatment of Primary Gynecomastia: An Observational Study of Tamoxifen Versus Observation Alone, in The breast journal, DOI:10.1111/tbj.12033.
(EN) G. N. Hortobagyi e F. J. Esteva, Comparative assessment of lipid effects of endocrine therapy for breast cancer: Implications for cardiovascular disease prevention in postmenopausal women, in The Breast, vol. 15, n. 3, 1º giugno 2006, pp. 301–312, DOI:10.1016/j.breast.2005.08.033. URL consultato il 5 dicembre 2018.
(EN) Myles Brown, Leonard P. Freedman e Timothy F. Lane, Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival, in The EMBO Journal, vol. 27, n. 3, 6 febbraio 2008, pp. 535–545, DOI:10.1038/sj.emboj.7601984. URL consultato il 5 dicembre 2018.

embopress.org

emboj.embopress.org

(EN) Myles Brown, Leonard P. Freedman e Timothy F. Lane, Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival, in The EMBO Journal, vol. 27, n. 3, 6 febbraio 2008, pp. 535–545, DOI:10.1038/sj.emboj.7601984. URL consultato il 5 dicembre 2018.

europa.eu

ema.europa.eu

Orphan designation: tamoxifen citrate for treatment of cystic fibrosis, su ema.europa.eu. URL consultato il 27 dicembre 2018.
Orphan designation: tamoxifen citrate for treatment of Duchenne muscular dystrophy, su ema.europa.eu. URL consultato il 27 dicembre 2018.

news-medical.net

(EN) Tamoxifen Mechanism, su News-Medical.net, 9 gennaio 2010. URL consultato il 4 dicembre 2018.

nih.gov

ncbi.nlm.nih.gov

R. L. Sutherland, M. D. Green e R. E. Hall, Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle, in European Journal of Cancer & Clinical Oncology, vol. 19, n. 5, 1983-5, pp. 615–621. URL consultato il 4 dicembre 2018.
(EN) Scott M. Lippman e Michael B. Sporn, Agents for Chemoprevention and Their Mechanism of Action, in Holland-Frei Cancer Medicine. 6th edition, 2003. URL consultato il 4 dicembre 2018.
Anne Z. Steiner, Mishka Terplan e Richard J. Paulson, Comparison of tamoxifen and clomiphene citrate for ovulation induction: a meta-analysis, in Human Reproduction (Oxford, England), vol. 20, n. 6, 2005-6, pp. 1511–1515, DOI:10.1093/humrep/deh840. URL consultato l'8 gennaio 2019.
Jamie L. Eberling, Christine Wu e Regina Tong-Turnbeaugh, Estrogen- and tamoxifen-associated effects on brain structure and function, in NeuroImage, vol. 21, n. 1, 2004-1, pp. 364–371. URL consultato il 5 dicembre 2018.
S. R. Goldstein, S. Siddhanti e A. V. Ciaccia, A pharmacological review of selective oestrogen receptor modulators, in Human Reproduction Update, vol. 6, n. 3, 2000-5, pp. 212–224. URL consultato il 5 dicembre 2018.

oadoi.org

Kuhl H., Pharmacology of estrogens and progestogens: influence of different routes of administration, in Climacteric, vol. 8, n. 1, DOI:10.1080/13697130500148875.
Jordan VC (Oct 1993), "Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer"., in British Journal of Pharmacology, vol. 110, n. 2, DOI:10.1111/j.1476-5381.1993.tb13840.x.
Ruth James BA, MEd, FRCS Farid Ahmed MBBS, FRCS Giles Cunnick BSc, MD, FRCS, The Efficacy of Tamoxifen in the Treatment of Primary Gynecomastia: An Observational Study of Tamoxifen Versus Observation Alone, in The breast journal, DOI:10.1111/tbj.12033.

thebreastonline.com

(EN) G. N. Hortobagyi e F. J. Esteva, Comparative assessment of lipid effects of endocrine therapy for breast cancer: Implications for cardiovascular disease prevention in postmenopausal women, in The Breast, vol. 15, n. 3, 1º giugno 2006, pp. 301–312, DOI:10.1016/j.breast.2005.08.033. URL consultato il 5 dicembre 2018.

web.archive.org

Center for Drug Evaluation and Research, "Tamoxifen Information: reducing the incidence of breast cancer in women at high risk", in U.S. Food and Drug Administration., 19 giugno 2007. URL consultato l'8 gennaio 2019 (archiviato dall'url originale il 19 giugno 2007).

worldcat.org

Foye, William O., Lemke, Thomas L. e Williams, David A., Foye's principi di chimica farmaceutica, 6. ed. it. sulla 7. americana., Piccin, 2014, ISBN 9788829926633, OCLC 894965937. URL consultato il 4 dicembre 2018.